产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 304-55-2 |
|---|---|---|---|
| 分子式 | C4H6O4S2 | 纯度 | >98% |
| 分子量 | 182.22 | 货号 | abs47028081 |
| 规格 | 10mg | 供货周期 | 现货 |
| 主要用途 | is a Lead Chelator. | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Succimer 304-55-2
| 产品描述 | |
| 描述 | Succimer is a Lead Chelator. The mechanism of action of succimer is as a Lead Chelating Activity. |
| 纯度 | >98% |
| 储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 别名 | 二巯基丁二酸;Dimercaptosuccinic acid; DMSA |
| 外观 | 白色结晶性粉末 |
| 可溶性/溶解性 | DMSO :36 mg/mL (197.56 mM) Ethanol:3 mg/mL (16.46 mM) |
| 生物活性 | |
| In vivo(体内研究) | Succimer is a widely used chelating agent for the treatment of Pb poisoning. Red blood cells (RBCs) from lead exposed animals treated with NAC or Succimer are shown to have significantly higher glutathione (GSH) levels and diminished malondialdehyde (MDA) levels when compare to the lead group. Succimer administration also results in decreased glucose 6-phosphate dehydrogenase (G6PD) activity in RBCs from lead exposed animals. Succimer treatment produces a significant reduction in blood lead levels for both lead exposure conditions: the High Pb-succ group has blood lead levels that are 27% of the blood lead levels of the High Pb group at the end of treatment. Succimer is effective in substantially reducing brain lead, as brain lead levels in the High Pb-succ group are 37% of levels in the High Pb group. |
| 参考文献 | |
| 参考文献 |
|
| 研究领域 | |
| 研究领域 | Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询